Effects of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice

Behavioural Brain Research

Volumn 121, Issue 1-2, 2001, Pages 189-197

  Manzanedo, Carmen ^a   Aguilar, María A ^a   Rodríguez Arias, Marta ^a   Miarro, José ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Clozapine; CPP; Haloperidol; Morphine; Raclopride; Risperidone; SCH 23390; U 99194A maleate

Indexed keywords

2 DIPROPYLAMINO 5,6 DIMETHOXYINDAN; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CLOZAPINE; DOPAMINE RECEPTOR; HALOPERIDOL; MORPHINE; RACLOPRIDE; RISPERIDONE;

ANIMAL EXPERIMENT; ARTICLE; AVERSION; CONDITIONING; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DRUG EFFECT; HYPERACTIVITY; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; REWARD;

ANIMALS; AVOIDANCE LEARNING; BRAIN; CHOICE BEHAVIOR; CONDITIONING, CLASSICAL; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MORPHINE; MOTIVATION; ORIENTATION; RECEPTORS, DOPAMINE;

EID: 0035103779     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(01)00164-4     Document Type: Article

References (71)

1. D1 receptor blockade stereo-specifically impairs the acquisition of drug-conditioned place preference and place aversion
2. SCH 23390 blocks drug-conditioned place-preference and place aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine receptor blockade?
3. Non-psychostimulant drugs of abuse and anxiogenic drugs activate with differential selectivity dopamine transmission in the nucleus accumbens and in the medial prefrontal cortex of the rat
4. A single brain stem substrate mediates the motivational effects of both opiates and food in nondeprived rats but not in deprived rats
5. Neurobiology of motivation: Double dissociation of two motivational mechanisms mediating opiate reward in drug-naïve versus drug-dependent animals
6. Differences in drug-induced place conditioning between BALB/c and C57B1/6 mice
7. Effects of test conditions on the outcome of place conditioning with morphine and naltrexone in mice
8. Heroin reward is dependent on a dopaminergic substrate
9. L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests
10. Effects of dopaminergic and glutamatergic antagonists on the acquisition and expression of cocaine conditioning place preference
11. Isolation impairs place preference conditioning to morphine but not aversive learning in mice
12. The NMDA receptor antagonist dizocilpine (MK-801) stereoselectively inhibits morphine-induced place preference conditioning in mice
13. Psychobiology of the role of DA in drug abuse and addiction
14. A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use
15. Drug addiction as dopamine-dependent associative learning disorder
16. Neurobiology of opiate abuse
17. Conditioned place aversion produced by FG 7142 is attenuated by haloperidol
18. The role of dopamine D4 receptor in the induction of behavioral sensitization to amphetamine and accompanying biochemical and molecular adaptations
19. Differential involvement of D1 and D2 dopamine receptors in the expression of morphine withdrawal in the rat
20. The effects of selective dopamine D1 or D2 receptor antagonists on the establishment of agonist-induced place conditioning in rats
21. Effects of typical, atypical, and novel antipsychotic drugs on amphetamine-induced place conditioning in rats
22. Effects of dopamine D3 preferring compounds on conditioned place preference and intracranial self-stimulation in the rat
23. Effects of the dopamine D3- and autoreceptor-preferring antagonist (-)-DS121 on locomotor activity, conditioned place preference and intracranial self-stimulation in the rat
24. Clozapine attenuates cocaine conditioned place preference
25. RBI-257: a highly potent dopamine D4 receptor-selective ligand
26. Blockade of D-1 receptors by SCH23390 antagonizes morphine-and amphetamine-induced place preference conditioning
27. Neuroleptics block the positive reinforcing effects of amphetamine but not of morphine as measured by place conditioning
28. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors
29. Selective dopamine D4 receptor antagonists reverse apomorphine-induced blockade of prepulse inhibition
30. 3 antagonists on spontaneous motor activity and morphine-induced hyperactivity in male mice
31. Involvement of dopamine D(1) and D(2) receptors in the ethanol-associated place preference in rats exposed to conditioned fear stress
32. Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies
33. Olanzapine attenuates the reinforcing effects of cocaine
34. Deprivation state switches the neurobiological substrates mediating opiate reward in the ventral tegmental area
35. Neuroleptics block high- but not low-dose heroin place preferences: further evidence for a two-system model of motivation
36. Effects of ritanserin on the rewarding properties of d-amphetamine, morphine and diazepam revealed by conditioned place preference in rats
37. Differential effects of ventral striatal lesions on the conditioned place preference induced by morphine or amphetamine
38. The development of a conditioned place preference to morphine: effects of microinjections into various CNS sites
39. Reinforcing properties of fencamphamine: involvement of dopamine and opioid receptors
40. Involvement of opioid m1-receptors in opioid-induced acceleration of striatal and limbic dopaminergic transmission
41. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the 'shell' as compared with the 'core' of the rat nucleus accumbens
42. Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-Methyl-D-apartate receptor antagonist, Memantine
43. Haloperidol reduces ethanol-induced motor activity stimulation but not conditioned place preference
44. Effect of 5,7-dihydroxytryptamine lesion on mianserin induced conditioned place aversion and on 5-hydroxytryptamine 1C receptors in the rat brain
45. Lack of specific effects of selective D1 and D2 dopamine antagonists vs. Risperidone on morphine-induced hyperactivity
46. The dopamine receptor agonist 7-OH-DPAT modulates the acquisition and expression of morphine-induced place preference
47. Substituted 4-aminopiperidines having high in vitro affinity and selectivity for the cloned human dopamine D4 receptor
48. Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors
49. Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of mu- and k-opioid agonists
50. Motivational effects of opioids: influence of D-1 versus D-2 receptor antagonists
51. Examination of the neurochemical substrates mediating the motivational effects of opioids: Role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors
52. Neuroanatomical substrates mediating the aversive effects of D-1 dopamine receptor antagonists
53. The dopamine hypothesis of reward: past and current status
54. Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system
55. A role of the mesolimbic dopamine system in the reinforcing properties of diazepam
56. Chronic flupentixol treatment potentiates the reinforcing properties of systemic heroin administration
57. Sertindole antagonizes morphine-, cocaine-, and methamphetamine-induced place preference in the rat
58. Morphine-induced place preference in the CXBK mouse: characteristics of mu opioid receptor subtype
59. Blockade of d-opioid receptors prevents morphine-induced place preference in mice
60. Effects of the histaminergic system on the morphine-induced conditioned place preference in mice
61. Effect of the highly selective and non-peptide δ opioid receptor agonist TAN-67 on the morphine-induced place preference in mice
62. Antisense oligodeoxynucleotide to δ opioid receptors attenuates morphine dependence in mice
63. A dopamine-m1 opioid link in the rat ventral tegmentum shared by palatable food (Fonzies) and non-psychostimulant drugs of abuse
64. Clozapine's effects on ethanol's motivational properties
65. Activation of ventral tegmental gabaB receptors inhibits morphine-induced place preference in rats
66. Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioral sensitization
67. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues
68. Drug-activation of brain reward pathways
69. The amphetamine-like reinforcing effect and mechanism of L-deprenyl on conditioned place preference in mice
70. Dopamine release in the nucleus accumbens during heroin self-administration is modulated by kappa opioid receptors: an in vivo fast-cyclic voltammetry study
71. Centrally administered galanin blocks morphine-place preference in the mouse